041204naseem.ppt

Dr. Naseem Rahman
d) The attitude of health workers in sterilizing a female with out partner’s consent. Often after this happens-the husband uses this excuse to re-marry.
1) Pills- Irregular, usage causes DUB and is 2) IUCD- After Insertion in multipara,IUD may be lost .Even the patient may not be aware of it- resulting pregnancy. Husband complains about painful thread.
3) Norplant- Expensive and available only in 4) Tubal ligation- Is hated by both males and females. Because this requires hospitalization costs money and both sexes believe that is causes loss of libido.
j) Depo -provera injection. Not available sterilization- ( cost us$ 2-3 per person, no hospitalization) 2900 patients have received QS since 1975
to date.
Complications are-

• 2 tubal pregnancy• 4 normal pregnancy• 1 ca-cervix• for reasons unknown and unproven this has been Procedure of Qs
until it touches the roof of the uterine cavity .Then push in the desired number of quinacrine pellets and the ampicilline pellet.
is covered with oral contraception or injectablecontraception. The procedure has to be repeated for 2 cycles.
painless, non-expensive with no loss of working hours and etc.
This process should be tried under proper scientific monitoring and then used is poor countries on willing females patients.
The basis of success of sterilization in males and females depends upon their understanding,willingness and it should be voluntary.
This can only happened when we take more time

Source: http://www.rotary1830.de/RFPD/aktivitaeten_int/Dokumente/041204_B1_contraception.pdf

sanjuancollege.edu

Clin Rheumatol (2007) 26:1843–1849DOI 10.1007/s10067-007-0587-0Exercise-based motivational interviewing for female patientswith fibromyalgia: a case seriesDennis Ang & Ramesh Kesavalu & Jennifer R. Lydon &Kathleen A. Lane & Silvia BigattiReceived: 6 December 2006 / Revised: 31 January 2007 / Accepted: 1 February 2007 / Published online: 20 February 2007Abstract The objective

Viagra, inn-sildenafil

EUROPEES OPENBAAR BEOORDELINGSRAPPORT (EPAR) EPAR-samenvatting voor het publiek Dit document is een samenvatting van het Europees openbaar beoordelingsrapport (EPAR). Doel ervan is uit te leggen hoe de op studies gebaseerde beoordeling van het Comité voor geneesmiddelen voor menselijk gebruik (CHMP) heeft geleid tot de aanbevelingen wat betreft de gebruiksvoorwaarden. Lees de b

Copyright © 2013-2018 Pharmacy Abstracts